Phase I study of veliparib in combination with gemcitabine

Ronald G. Stoller(UPMC Hillman Cancer Center), John C. Schmitz(University of Pittsburgh), Fei Ding(UPMC Hillman Cancer Center), Shannon Puhalla(University of Pittsburgh), Chandra P. Belani(Penn State Milton S. Hershey Medical Center), Leonard J. Appleman(UPMC Hillman Cancer Center), Yan Lin(University of Pittsburgh), Yixing Jiang(Penn State Milton S. Hershey Medical Center), Salah Almokadem(Penn State Milton S. Hershey Medical Center), Daniel P. Petro(University of Pittsburgh), Julianne L. Holleran(UPMC Hillman Cancer Center), Brian F. Kiesel(UPMC Hillman Cancer Center), R. Ken Czambel(UPMC Hillman Cancer Center), Benedito A. Carneiro(University of Pittsburgh), Emmanuel Kontopodis(UPMC Hillman Cancer Center), Pamela A. Hershberger(Roswell Park Comprehensive Cancer Center), Madani Rachid(UPMC Hillman Cancer Center), Alice P. Chen(National Cancer Institute), Edward Chu(UPMC Hillman Cancer Center), Jan H. Beumer(University of Pittsburgh)
Cancer Chemotherapy and Pharmacology
August 2, 2017
Cited by 13Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis